Literature DB >> 22503268

Intensive luteal-phase support with oestradiol and progesterone after GnRH-agonist triggering: does it help?

Raoul Orvieto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22503268     DOI: 10.1016/j.rbmo.2012.03.005

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


× No keyword cloud information.
  8 in total

Review 1.  Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.

Authors:  Ali Abbara; Sophie A Clarke; Waljit S Dhillo
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

2.  An update on the prevention of ovarian hyperstimulation syndrome.

Authors:  Omar El Tokhy; Julia Kopeika; Tarek El-Toukhy
Journal:  Womens Health (Lond)       Date:  2016-08-19

3.  Contribution to More Patient-Friendly ART Treatment: Efficacy of Continuous Low-Dose GnRH Agonist as the Only Luteal Support-Results of a Prospective, Randomized, Comparative Study.

Authors:  Céline Pirard; Ernest Loumaye; Pascale Laurent; Christine Wyns
Journal:  Int J Endocrinol       Date:  2015-04-05       Impact factor: 3.257

Review 4.  The Luteal Phase after GnRHa Trigger-Understanding An Enigma.

Authors:  Kathrine Leth-Moller; Sandra Hammer Jagd; Peter Humaidan
Journal:  Int J Fertil Steril       Date:  2014-11-01

Review 5.  Gonadotropin-releasing hormone agonist for ovulation trigger - OHSS prevention and use of modified luteal phase support for fresh embryo transfer.

Authors:  Juan Carlos Castillo; Thor Haahr; María Martínez-Moya; Peter Humaidan
Journal:  Ups J Med Sci       Date:  2020-05-04       Impact factor: 2.384

6.  HCG (1500IU) administration on day 3 after oocytes retrieval, following GnRH-agonist trigger for final follicular maturation, results in high sufficient mid luteal progesterone levels - a proof of concept.

Authors:  Jigal Haas; Alon Kedem; Ronit Machtinger; Shir Dar; Ariel Hourvitz; Gil Yerushalmi; Raoul Orvieto
Journal:  J Ovarian Res       Date:  2014-04-03       Impact factor: 4.234

7.  Impact of GnRH agonist triggering and intensive luteal steroid support on live-birth rates and ovarian hyperstimulation syndrome: a retrospective cohort study.

Authors:  Stamatina Iliodromiti; Vuong Thi Ngoc Lan; Ho Manh Tuong; Phung Huy Tuan; Peter Humaidan; Scott M Nelson
Journal:  J Ovarian Res       Date:  2013-12-26       Impact factor: 4.234

8.  Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma.

Authors:  Raoul Orvieto
Journal:  J Ovarian Res       Date:  2013-11-05       Impact factor: 4.234

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.